U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 84

1.
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes
Alessia Parodi, Florinda Battaglia, Francesca Kalli, Francesca Ferrera, Giuseppina Conteduca, Samuele Tardito, Silvia Stringara, Federico Ivaldi, Simone Negrini, Giacomo Borgonovo, Alchiede Simonato, Paolo Traverso, Giorgio Carmignani, Daniela Fenoglio, Gilberto Filaci
Cancer Immunol Immunother. 2013 May; 62(5): 851–862. Published online 2013 Jan 29. doi: 10.1007/s00262-013-1392-z
PMCID:
PMC11029015
AbstractArticlePDF–568K
2.
Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19
Alaa Elsaghir, Ehsan M. W. El-Sabaa, Asmaa M. Zahran, Sahar A. Mandour, Eman H. Salama, Sahar Aboulfotuh, Reham M. El-Morshedy, Stefania Tocci, Ahmed Mohamed Mandour, Wael Esmat Ali, Lobna Abdel-Wahid, Ibrahim M. Sayed, Mohamed A. El-Mokhtar
Int J Mol Sci. 2023 Dec; 24(24): 17614. Published online 2023 Dec 18. doi: 10.3390/ijms242417614
PMCID:
PMC10744088
AbstractArticlePDF–2.6M
3.
Cancer CD39 drives metabolic adaption and mal-differentiation of CD4+ T cells in patients with non-small-cell lung cancer
Ying Wang, Mengdi Liu, Lei Zhang, Xiyu Liu, Huiyan Ji, Yan Wang, Jun Gui, Yan Yue, Zhenke Wen
Cell Death Dis. 2023 Dec; 14(12): 804. Published online 2023 Dec 8. doi: 10.1038/s41419-023-06336-4
PMCID:
PMC10703826
AbstractArticlePDF–3.8M
4.
Human soluble CD39 displays substrate inhibition in a substrate-specific manner
Venkat M. K. Vadlamani, Kavinda K. J. Gunasinghe, Xavier W. Chee, Taufiq Rahman, Matthew T. Harper
Sci Rep. 2023; 13: 8958. Published online 2023 Jun 2. doi: 10.1038/s41598-023-36257-3
PMCID:
PMC10238538
AbstractArticlePDF–6.4M
5.
Biallelic variants in the ectonucleotidase ENTPD1 cause a complex neurodevelopmental disorder with intellectual disability, hypomyelination, and spastic paraplegia
Daniel G. Calame, Isabella Herman, Aren E. Marshall, Reza Maroofian, Karina Carvalho Donis, Jawid M. Fatih, Tadahiro Mitani, Haowei Du, Christopher M. Grochowski, Sergio Sousa, Somayeh Bakhtiari, Yoko A. Ito, Clarissa Rocca, Jill V. Hunter, V. Reid Sutton, Lisa T. Emrick, Kym M. Boycott, Alexander Lossos, Yakov Fellig, Eugenia Prus, Yosef Kalish, Vardiella Meiner, Manon Suerink, Claudia Ruivenkamp, Kayla Muirhead, Nebal W. Saadi, Maha S. Zaki, David L. Skidmore, Matthew Osmond, Thiago Oliveira Silva, Henry Houlden, David Murphy, Ehsan Ghayoorarimiani, Yalda Jamshidi, Asaad Ghanim Jaddoa, Homa Tajsharghi, Sheng Chih Jin, Zeynep Coban-Akdemir, Lorena Travaglini, Francesco Nicita, Shalini N. Jhangiani, Richard A. Gibbs, Jennifer E. Posey, Michael C. Kruer, Kristin D. Kernohan, Jonas A. Morales Saute, Adeline Vanderver, Davut Pehlivan, Dana Marafi, James R. Lupski
Ann Neurol. Author manuscript; available in PMC 2023 Aug 1.
Published in final edited form as: Ann Neurol. 2022 Aug; 92(2): 304–321. Published online 2022 May 28. doi: 10.1002/ana.26381
PMCID:
PMC10054521
AbstractArticlePDF–2.7M
6.
Assessment of CD39 expression in regulatory T‐cell subsets by disease severity in adult and juvenile COVID‐19 cases
Abdurrahman Simsek, Muhammed A. Kizmaz, Eren Cagan, Fatma Dombaz, Gulcin Tezcan, Ali Asan, H. Ibrahim Demir, S. Haldun Bal, Digdem Y. Ermis, Aslı G. Dilektaslı, Esra Kazak, E. Halis Akalin, H. Barbaros Oral, Ferah Budak
J Med Virol. 2022 May; 94(5): 2089–2101. Published online 2022 Jan 26. doi: 10.1002/jmv.27593
PMCID:
PMC9015412
AbstractArticlePDF–3.6M
7.
Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation
Elena Díaz-García, Sara García-Tovar, Enrique Alfaro, Ester Zamarrón, Alberto Mangas, Raúl Galera, José Juan Ruíz-Hernández, Jordi Solé-Violán, Carlos Rodríguez-Gallego, Ana Van-Den-Rym, Rebeca Pérez-de-Diego, Kapil Nanwani-Nanwani, Eduardo López-Collazo, Francisco García-Rio, Carolina Cubillos-Zapata
Front Immunol. 2022; 13: 847894. Published online 2022 Jan 31. doi: 10.3389/fimmu.2022.847894
PMCID:
PMC8841513
AbstractArticlePDF–3.9M
8.
Favorable function of Ectonucleoside triphosphate diphosphohydrolase 1 high expression in thyroid carcinoma
Jun-hua Luo, Yun-hua Zhu, Cheng Xiang
Hereditas. 2021; 158: 33. Published online 2021 Aug 31. doi: 10.1186/s41065-021-00198-6
PMCID:
PMC8408975
AbstractArticlePDF–4.8M
9.
CD39 Regulation and Functions in T Cells
Eleonora Timperi, Vincenzo Barnaba
Int J Mol Sci. 2021 Aug; 22(15): 8068. Published online 2021 Jul 28. doi: 10.3390/ijms22158068
PMCID:
PMC8348030
AbstractArticlePDF–1.1M
10.
Mass Cytometry Discovers Two Discrete Subsets of CD39−Treg Which Discriminate MGUS From Multiple Myeloma
Felix Marsh-Wakefield, Annabel Kruzins, Helen M. McGuire, Shihong Yang, Christian Bryant, Barbara Fazekas de St. Groth, Najah Nassif, Scott N. Byrne, John Gibson, Christina Brown, Stephen Larsen, Derek McCulloch, Richard Boyle, Georgina Clark, Douglas Joshua, Phoebe Joy Ho, Slavica Vuckovic
Front Immunol. 2019; 10: 1596. Published online 2019 Aug 2. doi: 10.3389/fimmu.2019.01596
PMCID:
PMC6688400
AbstractArticlePDF–1.4M
11.
CD39/NTPDase-1 expression and activity in human umbilical vein endothelial cells are differentially regulated by leaf extracts from Rubus caesius and Rubus idaeus
Dominika Dudzinska, Boguslawa Luzak, Magdalena Boncler, Joanna Rywaniak, Dorota Sosnowska, Anna Podsedek, Cezary Watala
Cell Mol Biol Lett. 2014 Sep; 19(3): 361–380. Published online 2014 Jul 18. doi: 10.2478/s11658-014-0202-8
PMCID:
PMC6275654
SummaryPDF–1.8M
12.
The ENTPD1 promoter polymorphism −860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk
James P. Maloney, Brian R. Branchford, Gary L. Brodsky, Maxwell S. Cosmic, David W. Calabrese, Christina L. Aquilante, Kelly W. Maloney, Joseph R. Gonzalez, Weiming Zhang, Kerrie L. Moreau, Kerri L. Wiggins, Nicholas L. Smith, Ulrich Broeckel, Jorge Di Paola
FASEB J. 2017 Jul; 31(7): 2771–2784. Published online 2017 Mar 16. doi: 10.1096/fj.201600344R
PMCID:
PMC6137499
AbstractArticle
13.
Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD
Elisabet Aliagas, Mariana Muñoz-Esquerre, Ester Cuevas, Oriol Careta, Daniel Huertas, Marta López-Sánchez, Ignacio Escobar, Jordi Dorca, Salud Santos
Respir Res. 2018; 19: 103. Published online 2018 May 28. doi: 10.1186/s12931-018-0793-0
PMCID:
PMC5972409
AbstractArticlePDF–5.8M
14.
The Nucleoside Triphosphate Diphosphohydrolase-1/CD39 Is Incorporated into Human Immunodeficiency Type 1 Particles, Where It Remains Biologically Active
Corinne Barat, Geneviève Martin, Adrien R. Beaudoin, Jean Sévigny, Michel J. Tremblay
J Mol Biol. Author manuscript; available in PMC 2017 Jan 16.
Published in final edited form as: J Mol Biol. 2007 Aug 3; 371(1): 269–282. Published online 2007 May 10. doi: 10.1016/j.jmb.2007.05.012
PMCID:
PMC5239664
AbstractArticlePDF–1.2M
15.
Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals
Fengqin Fang, Mingcan Yu, Mary M. Cavanagh, Jessica Hutter Saunders, Qian Qi, Zhongde Ye, Sabine Le Saux, William Sultan, Emerson Turgano, Cornelia L. Dekker, Lu Tian, Cornelia M. Weyand, Jörg J. Goronzy
Cell Rep. Author manuscript; available in PMC 2016 Apr 29.
Published in final edited form as: Cell Rep. 2016 Feb 9; 14(5): 1218–1231. Published online 2016 Jan 28. doi: 10.1016/j.celrep.2016.01.002
PMCID:
PMC4851554
AbstractArticlePDF–1.0M
16.
Defective renal water handling in transgenic mice over-expressing human CD39/NTPDase1
Yue Zhang, Kaiya L. Morris, Shannon K. Sparrow, Karen M. Dwyer, Keiichi Enjyoji, Simon C. Robson, Bellamkonda K. Kishore
Am J Physiol Renal Physiol. 2012 Aug 1; 303(3): F420–F430. Published online 2012 May 23. doi: 10.1152/ajprenal.00060.2012
PMCID:
PMC3433867
AbstractArticle
17.
Increased CD39 Nucleotidase Activity on Microparticles from Patients with Idiopathic Pulmonary Arterial Hypertension
Scott H. Visovatti, Matthew C. Hyman, Diane Bouis, Richard Neubig, Vallerie V. McLaughlin, David J. Pinsky
PLoS One. 2012; 7(7): e40829. Published online 2012 Jul 11. doi: 10.1371/journal.pone.0040829
PMCID:
PMC3394716
AbstractArticlePDF–1.5M
18.
Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection
Yan Tang, Li Jiang, Yanhua Zheng, Bing Ni, Yuzhang Wu
BMC Immunol. 2012; 13: 17. Published online 2012 Apr 11. doi: 10.1186/1471-2172-13-17
PMCID:
PMC3364870
AbstractArticlePDF–5.4M
19.
Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury
Ming Cai, Zachary M. Huttinger, Heng He, Weizhi Zhang, Feng Li, Lauren A. Goodman, Debra G. Wheeler, Lawrence J. Druhan, Jay L. Zweier, Karen M. Dwyer, Guanglong He, Anthony JF d'Apice, Simon C Robson, Peter J. Cowan, Richard J. Gumina
J Mol Cell Cardiol. Author manuscript; available in PMC 2012 Dec 1.
Published in final edited form as: J Mol Cell Cardiol. 2011 Dec; 51(6): 927–935. Published online 2011 Sep 12. doi: 10.1016/j.yjmcc.2011.09.003
PMCID:
PMC3245748
AbstractArticlePDF–2.5M
20.
T –cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus
Matthew J. Loza, A. Shane Anderson, Kenneth S. O’Rourke, James Wood, Islam U. Khan
Cell Immunol. Author manuscript; available in PMC 2012 Jul 18.
Published in final edited form as: Cell Immunol. 2011; 271(1): 110–117. Published online 2011 Jul 18. doi: 10.1016/j.cellimm.2011.06.010
PMCID:
PMC3168146
AbstractArticlePDF–2.8M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center